Market OpportunityDiabetes and Dyslipidemias

Type II

Diabetes* Dyslipidemia*

U.S. Prevalence 15 million(1) 40.8 million(2)

U.S. Diagnosed/Targeted 10 million(1) 8.1 million(2)

Est. cost of therapy $1,300 $650

U.S. Market Potential $13 billion $5.3 billion

• Significant percentage of diabetics are dyslipidemic

(1) Source: American Diabetes Association

(2) Source: Company estimates

Previous slide

Next slide

Back to first slide

View graphic version